OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y
OPK's Q1 earnings match estimates as pharma product sales rose, but revenue slides 25.7% after a smaller BioReference diagnostics base.
Open original sourceLoading market dashboard
OPK's Q1 earnings match estimates as pharma product sales rose, but revenue slides 25.7% after a smaller BioReference diagnostics base.
Open original source